MedTrace Logo

Ultrasound Evaluation Versus Direct Measurement of Uterine Cavity Length

NCT04425577 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2023-02-28

No results posted yet for this study

Summary

To determine if uterine cavity length on transabdominal pelvic ultrasound corresponds to uterine cavity length at time of IUD insertion. If transabdominal pelvic ultrasound is validated as a tool for measuring uterine cavity length, it can be used to guide physicians and subsequently patients in IUD insertion planning.

Conditions

  • Dysmenorrhea
  • Heavy Menstrual Bleeding
  • Contraception

Interventions

DIAGNOSTIC_TEST

Transabdominal Ultrasound

Transabdominal Ultrasound

Sponsors & Collaborators

  • Children's Mercy Hospital Kansas City

    lead OTHER

Principal Investigators

  • Ashli Lawson, MD · Children's Mercy Hospital Kansas City

  • Julie Strickland, MD · Children's Mercy Hospital Kansas City

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
22 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-06
Primary Completion
2022-12-31
Completion
2023-02-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04425577 on ClinicalTrials.gov